Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Aripiprazole Sandoz
Aripiprazole 5mg
Tablet
Novartis New Zealand Limited
Sandoz Private Limited, Navi Mumbai, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Aripiprazole Sandoz
Aripiprazole 10mg
Tablet
Novartis New Zealand Limited
Sandoz Private Limited, Navi Mumbai, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Aripiprazole Sandoz
Aripiprazole 15mg
Tablet
Novartis New Zealand Limited
Sandoz Private Limited, Navi Mumbai, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Aripiprazole Sandoz
Aripiprazole 20mg
Tablet
Novartis New Zealand Limited
Sandoz Private Limited, Navi Mumbai, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Aripiprazole Sandoz
Aripiprazole 30mg
Tablet
Novartis New Zealand Limited
Sandoz Private Limited, Navi Mumbai, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Vecure
Vecuronium bromide 10mg
Powder for injection
Mylan New Zealand Limited
Mylan Laboratories Limited, Bangalore, India
|
Dated this 15th day of February 2018.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013)
Gazette.govt.nz